Form 4: Establishment Labs Director Opts for Equity Compensation, Acquiring 585 Shares

Sentiment:

Insider Transaction Report


Establishment Labs Holdings Inc. Director Nicholas Sheridan Lewin acquired 585 common shares at $42.71 each, choosing equity in lieu of a quarterly cash retainer.

Summary

  • Director Nicholas Sheridan Lewin of Establishment Labs Holdings Inc. acquired 585 common shares on June 30, 2025.
  • The shares were acquired at a price of $42.71 per share.
  • This acquisition was made as the director elected to receive common shares instead of a quarterly cash retainer payment, in accordance with the Issuer's Outside Director Compensation Policy.
  • The shares were issued pursuant to the Issuer's 2018 Equity Incentive Plan, with the price determined by the closing price of the common shares on the last trading day of the quarter.
  • Following this transaction, Nicholas Sheridan Lewin directly beneficially owns 1,075,923 common shares and indirectly owns 14,190 common shares through his spouse.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even as part of compensation, generally indicates confidence in the company's future and aligns insider interests with shareholders. This is a positive signal, though not a direct 'buy' transaction.

Positives

  • Director Nicholas Sheridan Lewin increased his direct beneficial ownership by 585 common shares, indicating alignment of interests with shareholders.
  • The acquisition was part of a compensation policy where the director chose equity over cash, suggesting confidence in the company's future performance and long-term value.

Future Outlook

NA

Management Comments

  • Represents common shares elected to be received in lieu of a quarterly cash retainer payment in accordance with the Reporting Person's prior election under the Issuer's Outside Director Compensation Policy.
  • The common shares were issued pursuant to the Issuer's 2018 Equity Incentive Plan and determined based on the closing price of the Issuer's common shares on the last trading day of the quarter.

Industry Context

This Form 4 filing reflects a routine insider transaction where a director of Establishment Labs Holdings Inc. opted to receive equity as part of their compensation. Such transactions are common across industries as a mechanism for aligning management and director interests with those of shareholders, particularly in growth-oriented sectors like medical devices or biotechnology where equity compensation is prevalent.

Stakeholder Impact

  • Shareholders: The director's increased equity stake aligns their interests more closely with shareholders, potentially signaling confidence in the company's long-term value.
  • Management/Directors: The compensation policy allows directors flexibility in how they receive payment, potentially attracting and retaining talent.

Key Dates

DateDescription
06/30/2025Date of transaction where 585 common shares were acquired by Director Nicholas Sheridan Lewin.
07/01/2025Date the Form 4 was signed by Rajbir S. Denhoy, Chief Financial Officer, by power of attorney.

Recommendation

hold

Keywords

Establishment Labs Holdings Inc., ESTA, Form 4, Insider Transaction, Director Compensation, Share Acquisition, Equity Incentive Plan, Nicholas Sheridan Lewin, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.